VRCA earnings: a positive outcome, +12.2%

On March 13, 2020, Verrica Pharmaceuticals Inc. reached its earnings. The result was a positive outcome, and the stock moved +12.2% in the window around the event. It had already run -31.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.